Volume 16, Number 10—October 2010
Oral Fluid Testing during 10 Years of Rubella Elimination, England and Wales
|Region||No. reported cases||Incidence of reported cases*||No. oral fluid tests (% total reports)||No. cases confirmed by oral fluid testing||No. cases confirmed by serum testing||Annual incidence of confirmed cases*
|Confirmed by oral fluid testing†||Confirmed by serum testing||Total|
|East Midlands||1,336||319||1,065 (80)||3||9||0.09||0.21||0.29|
|North East||840||331||574 (68)||0||12||0.00||0.47||0.47|
|North West||1,662||245||1,505 (91)||12||13||0.25||0.19||0.37|
|South East||2,363||295||2,350 (99)||18||48||0.34||0.60||0.82|
|South West||1,109||224||857 (77)||13||40||0.31||0.81||1.07|
|West Midlands||1,235||234||821 (66)||12||10||0.33||0.19||0.42|
|Yorkshire and Humberside||1,903||382||1,260 (66)||7||22||0.20||0.44||0.58|
*Incidence per 1 million population. Annual incidence calculated by using 2001 census population figures.
†Adjusted for proportion of cases tested.
‡Several oral fluid tests were conducted for cases that were not formally reported during university outbreaks in 3 regions in 1999, including the South West, Eastern, and North West regions (17).
- Health Protection Agency. General information on rubella (German measles). London: The Agency; 2009. 2–2-0009.
- Ramsay ME, Brugha R, Brown DW, Cohen BJ, Miller E. Salivary diagnosis of rubella: a study of notified cases in the United Kingdom, 1991–4. Epidemiol Infect. 1998;120:315–9.
- Ramsay M, Gay N, Miller E, Rush M, White J, Morgan-Capner P, The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaign. Commun Dis Rep CDR Rev. 1994;4:R141–6.
- Regional World Health Organization Office for Europe. Strategic plan for measles and congenital rubella infection in the WHO European Region. Copenhagen: The Organization; 2003.
- World Health Organization Vaccine Assessment and Monitoring team DoVaB. WHO-recommended standards for surveillance of selected vaccine preventable diseases. Geneva: The Organization; 2003.
- Malamud D. Oral diagnostic testing for detecting human immunodeficiency virus-1 antibodies: a technology whose time has come. Am J Med. 1997;102:9–14.
- Mortimer PP, Parry JV. The use of saliva for viral diagnosis and screening. Epidemiol Infect. 1988;101:197–201.
- Parry JV, Mortimer PP. Non-invasive virological diagnosis: are saliva and urine specimens adequate substitutes for blood? Review of Medical Microbiology. 1991;1:73–8.
- Parry JV. Simple and reliable salivary tests for HIV and hepatitis A and B virus diagnosis and surveillance. Ann N Y Acad Sci. 1993;694:216–33.
- Nokes DJ, Enquselassie F, Vyse A, Nigatu W, Cutts FT, Brown DW. An evaluation of oral-fluid collection devices for the determination of rubella antibody status in a rural Ethiopian community. Trans R Soc Trop Med Hyg. 1998;92:679–85.
- Eckstein MB, Brown DW, Foster A, Richards AF, Gilbert CE, Vijayalakshmi P. Congenital rubella in south India: diagnosis using saliva from infants with cataract. BMJ. 1996;312:161.
- Nokes DJ, Enquselassie F, Nigatu W, Vyse AJ, Cohen BJ, Brown DW, Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia. Bull World Health Organ. 2001;79:588–95.
- Jin L, Vyse A, Brown DW. The role of RT-PCR assay of oral fluid for diagnosis and surveillance of measles, mumps and rubella. Bull World Health Organ. 2002;80:76–7.
- Vyse AJ, Jin L. An RT-PCR assay using oral fluid samples to detect rubella virus genome for epidemiological surveillance. Mol Cell Probes. 2002;16:93–7.
- Abernathy E, Cabezas C, Sun H, Zheng Q, Chen MH, Castillo-Solorzano C, Confirmation of rubella within 4 days of rash onset: comparison of rubella virus RNA detection in oral fluid with immunoglobulin M detection in serum or oral fluid. J Clin Microbiol. 2009;47:182–8.
- Miller E, Waight P, Gay N, Ramsay M, Vurdien J, Morgan-Capner P, The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme. Commun Dis Rep CDR Rev. 1997;7:R26–32.
- Rubella in university students. Commun Dis Rep CDR Wkly. 1999; 9:113, 116.
- Ramsay ME, Jin L, White J, Litton P, Cohen B, Brown D. The elimination of indigenous measles transmission in England and Wales. J Infect Dis. 2003;187(Suppl 1):S198–207.
- Savage E, Ramsay M, White J, Beard S, Lawson H, Hunjan R, Mumps outbreaks across England and Wales in 2004: observational study. BMJ. 2005;330:1119–20.
- Perry KR, Brown DW, Parry JV, Panday S, Pipkin C, Richards A. Detection of measles, mumps, and rubella antibodies in saliva using antibody capture radioimmunoassay. J Med Virol. 1993;40:235–40.
- Vyse AJ, Brown DW, Cohen BJ, Samuel R, Nokes DJ. Detection of rubella virus–specific immunoglobulin G in saliva by an amplification-based enzyme-linked immunosorbent assay using monoclonal antibody to fluorescein isothiocyanate. J Clin Microbiol. 1999;37:391–5.
- Vijaylakshmi P, Muthukkaruppan VR, Rajasundari A, Korukluoglu G, Nigatu W, Warrener LA, Evaluation of a commercial rubella IgM assay for use on oral fluid samples for diagnosis and surveillance of congenital rubella syndrome and postnatal rubella. J Clin Virol. 2006;37:265–8.
- Thomas HI, Morgan-Capner P, Enders G, O’Shea S, Caldicott D, Best JM. Persistence of specific IgM and low avidity specific IgG1 following primary rubella. J Virol Methods. 1992;39:149–55.
- Vyse AJ, Gay NJ, White JM, Ramsay ME, Brown DW, Cohen BJ, Evolution of surveillance of measles, mumps, and rubella in England and Wales: providing the platform for evidence-based vaccination policy. Epidemiol Rev. 2002;24:125–36.
- Tait DR, Ward KN, Brown DW, Miller E. Exanthem subitum (roseola infantum) misdiagnosed as measles or rubella. BMJ. 1996;312:101–2.
- Hogan PA. Viral exanthems in childhood. Australas J Dermatol. 1996;37(Suppl 1):S14–6.
- de Oliveira SA, Camacho LA, Medeiros Pereira AC, Bulhoes MM, Aguas AF, Siqueira MM. Performance of rubella suspect case definition: implications for surveillance. Rev Saude Publica. 2006;40:450–6.
- Recommendations from an ad hoc meeting of the WHO Measles and Rubella Laboratory Network (LabNet) on use of alternative diagnostic samples for measles and rubella surveillance. MMWR Morb Mortal Wkly Rep. 2008;57:657–60.
- Centers for Disease Control and Prevention. Mumps epidemic—United Kingdom, 2004–2005. MMWR Morb Mortal Wkly Rep. 2006;55:173–5.
- United Kingdom Department of Health. The MMR catch-up programme. 2008 Aug 7 [cited 2010 Jul 7]. http://www.dh.gov.uk/en/Publicationsandstatistics/Lettersandcirculars/Professionalletters/Chiefmedicalofficerletters/DH_086837
- Regional World Health Organization Office for Europe. Surveillance guidelines for measles, rubella and congenital rubella syndrome in the WHO European Region. Copenhagen: The Organization; 2009.
- EUVAC. Rubella surveillance report 2000–2007 [cited 2010 Jul 7]. http://www.euvac.net/graphics/euvac/pdf/rubella_report.pdf
- Vyse AJ, Gay NJ, Hesketh LM, Pebody R, Morgan-Capner P, Miller E. Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century. Epidemiol Infect. 2006;134:1303–12.